Teva Pharmaceuticals · 1 day ago
Intern - Production - Davie, FL
Teva Pharmaceuticals is a leading manufacturer of generic medicines, dedicated to making good health more affordable and accessible. The intern will gain in-depth insight into the Production department, working on meaningful projects and initiatives under the guidance of experienced colleagues.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
During the 13 week program, you will gain in-depth insight into the Production department
Supported by a mentor and experienced colleagues, you will be directly involved in our daily business and be assigned tasks within diverse projects
You will also play an important role in the development of concepts and initiatives
You will lead an innovative project aimed to combine traditional manufacturing concepts and fundamentals with new technologies available to you to successfully yield a significant and impactful project that can be quantified in terms of contribution to the Production Department but also look very well on your updated CV
Qualification
Required
Currently enrolled in Mechanical, Biomedical or similar program of Engineering or Sciences
Fundamental understanding and experience in Design tools such as Auto-CAD
Fundamental understanding and experience in Software and AI applications
Currently reside in commutable distance to Davie, FL
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.01BKey Investors
Royalty PharmaBerkshire Hathaway
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
2023-02-27Post Ipo Debt· $2.25B
Leadership Team
Recent News
2025-12-25
2025-12-24
Company data provided by crunchbase